Maternal allo-recognition of the fetus

Fertility and Sterility

Volumn 107, Issue 6, 2017, Pages 1269-1272

  Moffett, Ashley ^a   Chazara, Olympe ^a   Colucci, Francesco ^a  

^a UNIVERSITY OF CAMBRIDGE   (United Kingdom)

Author keywords

allo recognition; HLA class I molecules; NK cells; pregnancy; T cells

Indexed keywords

HLA C ANTIGEN; KILLER CELL IMMUNOGLOBULIN LIKE RECEPTOR;

ALLOGRAFT; HUMAN; MOTHER FETUS RELATIONSHIP; NATURAL KILLER CELL; PRIORITY JOURNAL; PROTEIN EXPRESSION; REVIEW; T LYMPHOCYTE; ANTIGEN PRESENTATION; BIOLOGICAL MODEL; FEMALE; FETOMATERNAL TRANSFUSION; FETUS; GENETICS; IMMUNOLOGY; INNATE IMMUNITY; LYMPHOCYTE; PASSIVE IMMUNIZATION; PLACENTA; PREGNANCY; REPRODUCTION; TROPHOBLAST;

ANTIGEN PRESENTATION; FEMALE; FETUS; HUMANS; IMMUNITY, INNATE; IMMUNITY, MATERNALLY-ACQUIRED; LYMPHOCYTES; MATERNAL-FETAL EXCHANGE; MODELS, GENETIC; MODELS, IMMUNOLOGICAL; PLACENTA; PLACENTATION; PREGNANCY; TROPHOBLASTS;

EID: 85020100850     PISSN: 00150282     EISSN: 15565653     Source Type: Journal    
DOI: 10.1016/j.fertnstert.2017.05.001     Document Type: Review

References (26)

1. Medawar, P., Some immunological and endocrinological problems raised by the evolution of viviparity in vertebrates. Symp Soc Exp Biol 7 (1953), 320–338.
2. Colucci, F., Moffett, A., Trowsdale, J., Medawar and the immunological paradox of pregnancy: 60 years on. Eur J Immunol 44 (2014), 1883–1885.
3. Moffett-King, A., Natural killer cells and pregnancy. Nat Rev Immunol 2 (2002), 656–663.
4. van Rood, J.J., van Leeuwen, A., Eernisse, J.G., Leucocyte antibodies in sera of pregnant women. Vox Sang 4 (1959), 427–444.
5. Howard, H., Martlew, V., McFadyen, I., Clarke, C., Duguid, J., Bromilow, I., et al. Consequences for fetus and neonate of maternal red cell allo-immunisation. Arch Dis Child Fetal Neonatal Ed 78 (1998), F62–F66.
6. Parham, P., The immune system. 4th ed., 2015, Garland Science, New York.
7. Moffett, A., Colucci, F., Uterine NK cells: active regulators at the maternal-fetal interface. J Clin Invest 124 (2014), 1872–1879.
8. Apps, R., Gardner, L., Moffett, A., A critical look at HLA-G. Trends Immunol 29 (2008), 313–321.
9. Tilburgs, T., Roelen, D.L., van der Mast, B.J., de Groot-Swings, G.M., Kleijburg, C., Scherjon, S.A., et al. Evidence for a selective migration of fetus-specific CD4+CD25bright regulatory T cells from the peripheral blood to the decidua in human pregnancy. J Immunol 180 (2008), 5737–5745.
10. Tilburgs, T., Scherjon, S.A., van der Mast, B.J., Haasnoot, G.W., Versteeg-v.d.Voort-Maarschalk, M.M., Roelen, D.L., et al. Fetal-maternal HLA-C mismatch is associated with decidual T cell activation and induction of functional T regulatory cells. J Reprod Immunol 82 (2009), 147–156.
11. Nancy, P., Erlebacher, A., T cell behavior at the maternal-fetal interface. Int J Dev Biol 58 (2014), 189–198.
12. Marder, W., Littlejohn, E.A., Somers, E.C., Pregnancy and autoimmune connective tissue diseases. Best Pract Res Clin Rheumatol 30 (2016), 63–80.
13. Mertz, D., Geraci, J., Winkup, J., Gessner, B.D., Ortiz, J.R., Loeb, M., Pregnancy as a risk factor for severe outcomes from influenza virus infection: A systematic review and meta-analysis of observational studies. Vaccine 35 (2017), 521–528.
14. Versteeg, R., NK cells and T cells: mirror images?. Immunol Today 13 (1992), 244–247.
15. Ljunggren, H.G., Karre, K., In search of the missing self: MHC molecules and NK cell recognition. ImmunolToday 11 (1990), 237–244.
16. King, A., Loke, Y.W., On the nature and function of human uterine granular lymphocytes. Immunol Today 12 (1991), 432–435.
17. King, A., Balendran, N., Wooding, P., Loke, Y.W., Cd3– Leukocytes Present in the Human Uterus During Early Placentation: Phenotypic and Morphologic Characterization of the Cd56++ Population. Dev Immunol 1 (1991), 169–190.
18. Moffett, A., Shreeve, N., First do no harm: uterine natural killer (NK) cells in assisted reproduction. Hum Reprod 30 (2015), 1519–1525.
19. Trundley, A., Moffett, A., Human uterine leukocytes and pregnancy. Tissue Antigens 63 (2004), 1–12.
20. Ruggeri, L., Mancusi, A., Urbani, E., Velardi, A., Identifying NK Alloreactive donors for haploidentical hematopoietic stem cell transplantation. Methods Mol Biol 1393 (2016), 141–145.
21. Murphy, W.J., Parham, P., Miller, J.S., NK Cells-From Bench to Clinic. Biol Blood Marrow Transpl 18 (2012), S2–S7.
22. Parham, P., MHC class I molecules and KIRs in human history, health and survival. Nat Rev Immunol 5 (2005), 201–214.
23. Shaffer, B.C., Hsu, K.C., How important is NK alloreactivity and KIR in allogeneic transplantation?. Best Pract Res Clin Haematol 29 (2016), 351–358.
24. Chazara, O., Xiong, S., Moffett, A., Maternal KIR and fetal HLA-C: a fine balance. J Leukoc Biol 90 (2011), 703–716.
25. Nakimuli, A., Chazara, O., Hiby, S.E., Farrell, L., Tukwasibwe, S., Jayaraman, J., et al. A KIR B centromeric region present in Africans but not Europeans protects pregnant women from pre-eclampsia. Proc Natl Acad Sci U S A 112 (2015), 845–850.
26. Hiby, S.E., Apps, R., Sharkey, A.M., Farrell, L.E., Gardner, L., Mulder, A., et al. Maternal activating KIRs protect against human reproductive failure mediated by fetal HLA-C2. J Clin Invest 120 (2010), 4102–4110.